Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer
NCT00417274
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Cancer
Interventions
DRUG:
Quinacrine
Sponsor
Cleveland BioLabs